Cv-1/99 update



Stephen R. Shorofsky, M.D., Ph.D.

Professor of Medicine

University of Maryland School of Medicine

3/29/16

Work Address University of Maryland Medical Center

Division of Cardiology

22 S. Greene Street, Room N3W77

Baltimore, Maryland 21201

(410) 328-6056

(410) 328-2062 (fax)

sshorofsky@medicine.umaryland.edu

Education

1978 Sc.B. Brown University, Providence RI

Bioengineering, Magna Cum Laude

1983 Ph.D. The University of Chicago, Chicago, IL

Department of Pharmacological and Physiological Sciences

Thesis: The mechanism of chloride secretion by the canine

trachea: an electrophysiological study.

1985 M.D. The University of Chicago, Chicago, IL

Postdoctoral Training

7/85 - 6/88 Internship and Residency in Internal Medicine

The University of Chicago, Chicago, Illinois

7/88 - 6/91 Cardiology Fellowship

The University of Chicago, Chicago, Illinois

7/91 - 6/92 Training in Clinical Electrophysiology

The University of Chicago, Chicago, Illinois

Certification and Licensure

1987 State of Illinois Medical License - Lic. No.: 036-075081

1988 Diplomate, American Board of Internal Medicine

1991 Board Certification in Cardiology

1994 Board Certification in Electrophysiology

1993 State of Maryland Medical License - Lic. No.: D44169

2001. Recertification in Cardiology

2004, 2014 Recertification in Clinical Electrophysiology

Faculty Positions

1991-1992 Research Associate - Clinical Instructor

The University of Chicago

Department of Medicine, Section of Cardiology

1992-1993 Assistant Professor

The University of Chicago

Department of Medicine, Section of Cardiology

1993-1999 Assistant Professor

University of Maryland School of Medicine

Department of Medicine, Division of Cardiology

1999-2000 Associate Professor

University of Maryland School of Medicine

Department of Medicine, Division of Cardiology

2000- 2007 Tenured Associate Professor

University of Maryland School of Medicine

Department of Medicine, Division of Cardiology

2007-present Tenured Professor

University of Maryland School of Medicine

Department of Medicine, Division of Cardiology

Professional Memberships

1991 to present Biophysical Society

1992 to present American Heart Association- Basic Science Council

1993 to present American College of Cardiology, Fellow

1993-1997 American Association for the Advancement of Science

1994 to present Heart Rhythm Society, Fellow

1995 to present Cardiac Electrophysiology Society

Awards and Honors

1978 Tau Beta Pi Engineering Honor Society

1978-1984 Medical Scientist Training Program

1983 Harry S. Ginsberg Memorial Award for outstanding research in the Department of Pharmacological and Physiological Sciences

1984 Alpha Omega Alpha Medical Honor Society

1999 American Society of Hypertension/Hoechst Marion Roussel Young Scholar Award

2008 Certificate of Teaching Excellence in Functional Systems Small Group Conferences

Administrative Service

Institutional Service

1994 Ad Hoc reviewer Special Research Initiative Support (SRIS) Study Section #5, Designated Research Initiative Fund (DRIF) Committee, University of Maryland School of Medicine

2002 – present Director, Clinical Electrophysiology, University of Maryland Medical Center

Oversee a staff of 8 clinical nurses, 2 research nurses and 3 faculty members. Developed a program that is performing more than 1600 cases per year with a budget of more than $6 million per year and generating gross revenue of more than $13 million for the hospital last year. Recruited two new faculty members in the last 3 years.

2002 – present Fellowship Program Director, Clinical Electrophysiology

University of Maryland Medical Center

Recruited and supervise on average 2 fellows per year. Have received 5 year certification from the RRC during the last visit.

2001 – 2005 Institutional Review Board member, University of Maryland, School of Medicine

2005 – present Ad Hoc Reviewer for the Institutional Review Board University of Maryland, School of Medicine

2000 – present Interviewer for Admissions Committee for University of Maryland School of Medicine

2000 – present Interviewer for Internal Medicine Residency Program, University of Maryland Medical Center

2005 – present Cardiovascular Executive Council, Division of Cardiology, University of Maryland, School of Medicine

2005 – present Cardiovascular Educational Committee, Division of Cardiology, University of Maryland, School of Medicine

2006 – present Physician Design Team for the Epic Computerized Medical Record Implementation, University of Maryland. Medical Center

Local Service

1993-1997 Member Peer Review Research Committee of the AHA, Maryland Affiliate

1994-1999 Member Research Committee of the AHA, Maryland Affiliate

1995-1996 Vice Chairman, AHA-Maryland Affiliate Peer Review Subcommittee

1997. Chairman, AHA-Maryland Affiliate Peer Review Subcommittee

National Service

1994 Ad Hoc consultant: S. C. O. R. in Ischemic Heart Disease, Sudden Cardiac Death & Heart Failure: RFA-HL-93-06-H

1995-2001 Extramural reviewer (VA Research Grants)

1996. Co-Chairperson, Abstract Session, “AV node; Physiology and Pathophysiology”, American Heart Association 69th Annual Scientific Sessions

1997. Co-Chairperson, Featured Research Abstract Session, “Coupling of Calcium Entry and Sarcoplasmic Reticulum Release”, American Heart Association, 71st Annual Scientific Sessions

1999-present Reviewer of abstracts submitted to the AHA Scientific Sessions

2002. Member of the Cellular Cardiovascular Physiology and Pharmacology Study Section of the America Heart Association (National)

2000-2003 Member of the Cellular Cardiovascular Physiology and Pharmacology Study Section of the America Heart Association (MidAtlantic Region)

2002-2003 Chair of the Cellular Cardiovascular Physiology and Pharmacology Study Section of the America Heart Association (MidAtlantic Region)

2002- 2005 Member Steering Committee of the MidAtlantic Region of the American Heart Association.

2003 Co-Chairperson, Feature Research Abstract Session “ Thomas W. Smith Memorial Lecture/ Cardiac Contractile Signaling in Disease,” American Heart Association, Annual Scientific Sessions.

2004-present Selection Committee Member for the Morowski Award; Guidant Corporation

2008 Member of the AHA Multidisciplinary/Collaborative Working Group (National)

2007- 2010 Member of the Solo Publication Committee

2014 CCEP Program Directors Subcommittee, Heart Rhythm Society

2015-16 NIH: SBIR grant proposal review committee. Development of a MRI compatible transseptal needle and sheath system..

Editorial Tasks

Reviewer

1995 to present American Journal of Cardiology

1997 to present Journal of Cardiac Electrophysiology

2000 to present American Journal of Physiology

2004 to present Heart Rhythm

2010 to present Journal of Heart and Lung Transplantation

2010 to present Circulation Research: EP

Teaching Services

Student Teaching

1989-1991 Medical Biology 303, University of Chicago

Cellular and Organ Physiology:

4 one hour lectures, 4 labs and 120 students

1991-1993 Medical Biology 503, University of Chicago

Advanced Training in ECG Interpretation

8 one hour lectures and 30 students

1993-present Laboratory Preceptor: University of Maryland School of Medicine

Cardiovascular section of first year Functional Systems; EKG small groups: Four 3 hour sessions; 25 student per session

1993-present Laboratory Preceptor for second year medical students: University of Maryland School of Medicine, Course MSPR 521; Four 3 hour sessions; 25 student per session

2000-2005 Lecturer in first year Functional Systems; University of Maryland School of Medicine; Two one hour lectures per year, 150 students

2000-present Lecturer in second year Medical Students: University of Maryland School of Medicine, Course MSPR 521; Two one hour lectures per year, 150 students

Resident and Fellow Teaching - University of Maryland Medical Center

1993-present Inpatient Attending Physician: (2 residents, 4 interns 1-2 students) 8 hours /day, 4-6 weeks/year.

1993-present EP service Attending Physician (3 EP fellows, on cardiology fellow), 10 hours/day 8 months/year. This also includes 2 hours per week of diadactic instruction. This includes supervision of and performing procedures, daily rounds, daily consultations and research supervision.

1996-2005 Morning Report Discussant

1999- present Electrophysiology lecture series for the Cardiology Fellows (9 hours per year, 12 Fellows)

2003- present Core curriculum for Residents (3 one hour lectures per year, 30 residents)

2005-present Lecutre series for Family Practice Residents (2 one hour lectures, 20 residents)

Trainees

Clinical Fellows

Daniel Weiss, M.D. – 1993-1994

David Riggio, M.D. – 1993

Zenaida Feliciano, M.D. – 1993-1994

Rangarao Tummala, M.D. – 1993-1995

Todd Florin, M.D. – 1994-1996

Alan Schneider, M.D. – 1994-1996

Koroush Khalighi, M.D. – 1994-1996

Michael Pelini, M.D. – 1996-1997

Mary Olsovsky, M.D. – 1996-1997

Randall Brockman, M.D. – 1996-1998

Michael Cooklin, M.D. – 1997-1998

Florin Degeratu, M.D. – 1998-1999

Malcolm Kirk, M.D. – 1996-2000

R.E. Hood, M.D. – 1998-1999

Karen MacMurdy, M.D. – 1999-2000

Thor Markwood M.D. – 2001-2002

Robert Joy, M.D. – 2000-2001

Scott Kirby, M.D. – 2000-2002

Ahmed Osman, M.D. – 2000-2001

Laura Murphy M.D. – 2001-2003

Paresh Shah M.D. – 2002-2004

Alex Ro M.D. 2003-2004

Ejaz Khan M.D. 2004-2006

Apostolos Vidourous M.D. 2004-2006

Manoj Pandy M.D. 2005-2006

Anthony Johnson M.D. 2006-2008

Christopher Kocher M.D. 2006-2007

Jagan Akella M.D. 2006-2008

Michael Nilius M.D. 2007-2008

Ahmed Hussein M.D. 2008-2009

Rishi Anand M.D. 2008-2010

Alejandro Jimenez M.D. 2009-2011

Richard Kuk, M.D. 2010-2011

Omar Shams, M.D. 2011-2012

Hiroko Beck, M.D. 2011-2013

Benjamin Remo, M.D. 2012-2014

Tom Klein, M.D. 2013-2014

Mousaber Ahmad D.O. 2014-2016

Shaun Bhatty, M.D. 2014-2016

John Duell, M.D. 2014-2016

Research Trainees

Former:

1996- 1998 Rajesh Aggarwal, Ph.D., Currently: Senior Associate Director, Safety Evaluation and Epidemiology, Pfizer Pharmaceuticals Group, Pfizer Inc.

Research project: Mechanism of excitation-contraction coupling in hypertensive heart disease.

1998- 1999 Bruno Stuyvers, Ph.D., Post-doctoral research fellow

Research project: Mechanism underlying spontaneous Ca2+ sparks in single mammalian ventricular cells.

1997-1999 Malcolm M. Kirk, M. D., Clinical cardiology fellow.

Research project: Ca2+ sparks in human and rat atrial cells.

1999-2003 Qun Sha, Ph.D., Research Associate

Research project: TTX-inhibitable Ca2+ current

2002- 2006 Eric Rashba, M.D. Co-Sponsor for K23 grant

Grant Support

Current Support

2002- present Medtronic, Inc

Principal Investigator

Fellowship Training Award

Direct $40,000 per year

2003-2006 Medtronic, Inc.

Principal Investigator (2% effort)

“Pacing for Sleep Apnea”.

Direct Costs: $37,500

Indirect Cost: $12,500

2003- 2010 Medtronic, Inc

Principal Investigator – local (5% effort)

“Subcutaneous Defibrillation”

Direct Costs: $15,000

Indirect Cost: $3,750

2003-2009 Guidant, Corp

Principal Investigator-local (2% effort)

“Decrease H-F”

Direct Costs: $153,600

Indirect Cost: $51,200

2004-2008 Medtronic, Inc

Principal Investigator-local (2% effort)

“Mavric VR ICD Follow-up”

Direct costs: $21,600

Indirect Cost: $5,400

2004-2006 Medtronic, Inc

Principal Investigator-local (1% effort)

“Characterization of Far Field Cardiac Signals and Muscle Noise Study”

Direct Costs: $8,400

Indirect Cost: $2,100

2004-2009 Medtronic, Inc

Principal Investigator-local (4% effort)

“MVP Trial (Managed Ventricular Pacing)”

Direct Costs: $27,600

Indirect Cost: $9,200

2004-2006 Medtronic, Inc

Principal Investigator-local (1% effort)

“TRENDS”

Direct Costs: $25,350

Indirect Cost: $8,450

2005-present- Guidant Corp.

Principal Investigator-local (4% effort)

“MADIT-CRT”

Direct Costs: $64,125

Indirect Cost: $21,375

2005-2006 Duska Pharmacuticals

Principal Investigator-local (2% effort)

“ATPace”

Direct Costs: $32,771

Indirect Cost: $10,924

2005-2006 Medtronic, Inc

Principal Investigator-local (2% effort)

“Acute Coupled Pacing”

Direct Costs: $12,188

Indirect Cost: $4,063

Prior Grant Support

1992-1993 Robert L. Wenger Senior Fellowship

American Heart Association of Metropolitan Chicago

Principal Investigator

“The role of T-type Ca2+ channels in heart cells”

direct award: $74,000

1997. National Institutes of Health

“The use of Electrophysiologic Studies to Guide Therapy for Non-Sustained Ventricular Tachycardia”

Co-Investigator

Total award: $120,638

1994-1996 Beginning Grant in Aid,

American Heart Association, Maryland Affiliate

Principal Investigator

“Role of T-type Ca2+ channels in heart cells”

Total award: $40,000

3 National Institutes of Health

“Antiarrhythmics vs Implantable Cardiac Defibrillator Clinical Trial”

Co-Investigator

Total award $64,800

1996-1999 Mentored Clinical Scientist Award

National Institutes of Health - Heart Lung and Blood Institute

Principal Investigator

“Mechanisms of Ca2+ handling in cardiac hypertrophy”

Total award: $258,390

1996-1999 VA Merit Review

Principal Investigator

“Determinants of Ca2+ homeostasis in cardiac hypertrophy and failure”

Total award: $261,100

1998-1999 Michael Bilitch Fellowship in Cardiac Pacing and Electrophysiology, North American Society of Pacing & Electrophysiology (NASPE)

Sponsor: Stephen Shorofsky

Principal Investigator: Malcolm M. Kirk, M.D.

“Calcium Sparks in Human Atrial Myocytes”

Total award: $35,000

2000. National Institute of Health/Heart Lung Institute

“Sudden Cardiac Death in Heart Failure Trial”

Co-Investigator (PI G Bardy)

Total Award: $265,000

1996-2001 National Institute of Health/Heart Lung Institute

“Atrial Fibrillation Follow-Up Investigation of Rhythm Management”

Co-Investigator (PI D. Wyse)

Total Award: $12,000

1999 American Society of Hypertension/Hoechst Marion Roussel Young Scholar Award. $10,000

1999-2004 VA Merit Award

Principal Investigator

“Determinants of Ca2+ Homeostasis in Cardiac Hypertrophy and Failure”

Total award: $700,000

2003 -2005 NIH RO1

Co-Investigator, (CW Balke)

“Ca Permeable Na Channels & Cardiac Cell Excitation”

Total Award $1,000,000

2005. NIH R01

Co-Investigator (CW Balke)

“Mechanisms of E-C Coupling in Atrial”

Total Award $1,000,000

2002-200 NIH K23 HL67198

Co-Sponsor

“Prognostic Significance of T-wave variablility”

Awarded to Dr. Rashba

Total award $375,000

Industry Sponsored

1995. Bristol-Meyers Squibb

Co-Investigator (PI: M Gold)

"Efficacy and Safety of d-Sotalol Versus Placebo in the Maintenance of Sinus Rhythm Following Pharmacologic or Electrical Cardioversion in Subjects with Sustained Atrial Fibrillation or Atrial Flutter".

Total award: $13,678

1995. Boston-Scientific

Co-Investigator (PI: M Gold)

"Clinical Trial of the Polaris LERF Ablation System for RF Catheter Ablation of Supraventricular Arrhythmias".

Total award: $8,986

1994. Merck & Co.

Co-Investigator (PI: M Gold)

"An Open-Label Study to Evaluate the Safety and Electrophysiologic Effects of MK-499 Administered Orally Once Daily (QD) or Twice Daily (BID) to Patients with Life-Threatening Ventricular Arrhythmias".

Total award: $90,340

1995. Bristol-Meyers Squibb

Co-Investigator (PI: M Gold)

"Comparison of Intravenous D-Sotalol and Placebo in the Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm". Total award: $14,524

1995. Bristol-Meyers Squibb

Co-Investigator (local PI: M Gold)

"Comparison of the Safety and Efficacy of d-Sotalol and d,L-Sotalol in Patients with Life-Threatening Ventricular Tachycardia (VT) and Ventricular Fibrillation: A Randomized, Double-Blind, Multicenter Study".

Total award: $3,000

1995. Bristol-Meyers Squibb

Co-Investigator (local PI: M Gold)

"Dose Ranging Study of Oral d-Sotalol in Patients with Life-Threatening Ventricular Arrhythmias".

Total award: $332,357

1995. Medtronic

Co-Investigator (PI: M Gold)

"The Clinical Investigation of the Medtronic Model 7202D Jewel Cardioverter/Defibrillator System with Transvene and Epicardial Leads".

Total award: $8,500

1995. Merck & Co.

Co-Investigator (local PI: M Gold)

"A Double-Blind, Randomized, Parallel, Sotalol-Controlled, Dose Confirmation Study to Investigate the Safety and Electrophysiologic Effects of MK-499 in Patients with Sustained Ventricular Tachyarrhythmias".

Total award: $343,576

1995. Medtronic

Co-Investigator (PI: M Gold)

"Clinical Investigation of Model 6937 SVC Lead with the Jewel System".

Total award: $5,000

1996. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

"Pectoral Clinical Investigation of the Ventak PRx III Model 1721 HC Hot Can Pulse Generator".

Total award: $7,500

1996. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

"Intracardiac Recordings of Ventricular Tachycardia (VT) and Atrial Fibrillation (AF) Signals During Implant of Endotak Leads".

Total award: $30,000

1997. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Effect of Pulse Width and Electrograms on Defibrillation Function”.

Total award: $60,000

1997. Medtronic

Co-Investigator (PI: M Gold)

“Clinical Investigation of the Medtronic Model 7218 SP1 Arrhythmia Management Device”.

Total award: $10,000

1997. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Biventricular Pacing in Congestive Heart Failure”

Total award: $6,000

1997. Cambridge Heart

Co-Investigator (PI: N Kavesh)

“Alternans Cardiac Electrical Stability Post MI”.

Total award: $50,000

1998. Mt. Sinai Medical Center

Co-Investigator (local PI: M Gold)

“DDD Versus DDDR Pacing: A Quality of Life Study”

Total award: $20,000

1999. Medtronic

Co-Investigator (PI: M Gold)

“Shock Polarity on Defibrillation Thresholds with Active Can Lead”.

Total award: $15,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Cardioversion and Discrimination of A-Fib with an Active Can ICD Lead System”.

Total award: $30,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (local PI: M Gold)

“Clinical Investigation of SELUTE

Picotip and SELUTE Picotip Atrial J Leads”.

Total award: $10,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Acute Clinical Test of Left Ventricular Access Leads”.

Total award: $36,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Effect of an Active Abdominal Pulse Generator on Defibrillation Thresholds”

Total award: $20,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Intracardiac Electrogram Morphology During Normal Sinus Rhythm”

Total award: $7,500

1998. Irvine Biomedical, Inc.

Co-Investigator (PI: M Gold)

“Therapy Ablation Catheter System”

Total award: $24,000

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Chronic Defibrillation Function with a Transvenous Lead System / Effect of Shock Polarity of DFT with Active Can Lead Systems”

Total award: $20,000

1998. Pacesetter, Inc.

Co-Investigator (PI: M Gold)

“Acute Hemodynamic Effects of Biventricular Pacing in Congestive Heart Failure”

Total award: $44,634

.

1998. Cardiac Pacemakers, Inc.

Co-Investigator (PI: M Gold)

“Endotak Endurance RX Defibrillation Lead System”

Total award: $12,000

1999. Cardiac Pacemakers, Inc.

Co-Investigator (local PI: M Gold)

“Low Energy Safety Study (LESS)”

Total award: $33,000

1998. Medtronic

Co-Investigator (PI: M Gold)

“Electrode Position on Ventricular DFT”.

Total award: $20,000

1999. Cardiac Pacemakers, Inc.

Co-Investigator (local PI: M Gold)

“Ventak CHF Biventricular Pacing Study”

Total award: $64,000

2004. Guidant Corporation

Principal Investigator - (local PI: M Gold)

“Clincial Evaluagtion of Ventak Prizm AVT”

Total award $118,750

Publications (Peer Reviewed)

1. Shorofsky SR, Field M, Fozzard HA. The cellular mechanism of active chloride secretion in vertebrate epithelia: studies in intestine and tracheal. Phil. Trans. R Soc Lond B 1982;299:597-607

2. Shorofsky SR, Field M, Fozzard HA. Electrophysiology of Cl secretion in canine trachea. J Membrane Biol 1983;72:105-115

3. Shorofsky, SR, Field, M, Fozzard, HA Mechanism of Cl secretion in canine trachea: changes in intracellular chloride activity with secretion. J Membrane Biol 1984;81:1-8

4. Shorofsky SR, Field M, Fozzard HA. Changes in intracellular sodium activity with chloride secretion in canine tracheal epithelium. Am J Physiol: Cell Physiol 1986;250:C646-650

5. Schoppa N, Shorofsky SR, How F, Nelson DJ. Voltage-gated chloride currents in cultured canine tracheal epithelial cells. J Membrane Biol 1988;108:73-90

6. January C., Shorofsky SR. Early afterdepolarizations: newer insights into cellular mechanisms. J Cardiovasc Electrophysiol 1990;1:161-169

7. Shorofsky SR, January CT. L- and T-type Ca2+ channels in canine cardiac Purkinje cells: single channel demonstration of L-type Ca2+ "window" current. Circ Res 1992;70(3):456-464

8. January CT, Cadman C, Shorofsky S. Mechanisms of triggered arrhythmias. Coronary Artery Disease. 1992;3(4):339-344

9. Gottlieb SS, Riggio DW, Lauria S, Riggio D, Peters RW, Shorofsky SR, Cines M, Froman D, Gold MR. High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure. JACC 1994;23(3):560-564

10. Xie JT, Cunningham P, Shorofsky S, Moscucci A, Cadman C, January CT. Induction of delayed afterdepolarizations and triggered arrhythmias in isolated Purkinje fibers: comparison of resibufogenin and acetylstrophanthidin. Acta Pharmacologica Sinica 1994;15(2):97-102

11. Peters RW, Weiss DN, Carliner NH, Feliciano Z, Shorofsky SR, Gold MR. Overdrive pacing for atrial flutter. Am. J. Cardiol. 1994;74:1021-1023

12. Riggio DW, Peters RW, Feliciano Z, Gottlieb SS, Shorofsky SR, Gold MR. Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. Am. J. Cardiol. 1995;75:1158-1161

13. Gold MR, Shorofsky SR. Transvenous defibrillation lead systems. J Cardiovasc Electrophysiology 1996;75:570-580

14. Tummala RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR. Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol 1996;78:309-312

15. Foster M, Peters RW, Froman D, Shorofsky SR, Gold MR. Electrophysiologic effects and predictors of success of combination therapy with class 1a and 1b antiarrhythmic drugs for sustained ventricular arrhythmias. Am J Cardiol 1996;78:47-50

16. Shorofsky SR, Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol 1996;78:313-316

17. Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996;78:540-543

18. Gold MR, Peters RW. Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996;28:1278-1282

19. Shorofsky SR, Foster AH, Gold MR. Effect of waveform tilt on defibrillation thresholds in humans. J of Cardiovasc Electrophysiol 1997;8(5):496-501

20. Khalighi K, Daly B, Leino EV, Shorofsky SR, Kavesh NG, Peters RW, Gold MR. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997;79:150-153

21. Kirk MM, Shorofsky SR, Khalighi K, Kavesh NG, Peters RW, Gold MR. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol 1997;79:502-505

22. Gold MR, Shorofsky SR, Metcalf MD, Feliciano Z, Fisher ML, Gottlieb SS. The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:679-681

23. Gold MR, Kavesh NG, Peters RW, Shorofsky SR. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol 1997;30(1):233-236

24. Gold MR, Khalighi K, Kavesh NG, Daly B, Peters RW, Shorofsky SR. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997;79:1623-1627

25. Khalighi K, Florin TJ, Peters, RW, Shorofsky SR, Gold MR. Distortion of intracardiac electrograms following defibrillator shocks for atrial tachyarrhythmias. PACE 1997;20(6):1682-1685

26. Khalighi K, Peters RW, Feliciano Z, Shorofsky SR, Gold MR. Comparison of class 1a/1b versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associate with coronary artery disease. Am J Cardiol 1997;80:591-594

27. Aggarwal R, Shorofsky SR, Goldman L, Balke CW. Tetrodotoxin blockable calcium currents in rat ventricular myocytes; a third type of cardiac cell sodium current. J Physiol 1997;505:353-369

28. Gold MR, Shorofsky SR. Strength-duration relationship for human transvenous defibrillation. Circulation 1997;96:3517-3520

29. Kavesh NG, Gosnell MR, Shorofsky SR, Gold MR, Polaris investigator group. comparison of power- and temperature- guided radiofrequency modification of the atrioventricular node. Am J Cardiol 1997;80:1444-1447

30. Gold MR, Foster AH, Shorofsky SR. Lead system optimization for transvenous defibrillation. Am J Cardiol 1997;80:1163-1167

31. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter defibrillators. PACE 1997;20(part II):208-211

32. Florin TJ, Weiss DN, Peters RW, Shorofsky SR, Gold MR. Induction of atrial fibrillation with low-energy defibrillator shocks in patients with implantable cardioverter defibrillators. Am J Cardiol 1997;80:960-962

33. Olsovsky MR, Hodgson DM, Shorofsky SR, Kavesh NG, Gold MR. Effect of biphasic waveforms on transvenous defibrillation thresholds in patients with coronary artery disease. Am J Cardiol 1997;80:1098-1100

34. Shorofsky SR, Izu L, Wier WG, Balke CW. Ca2+ sparks triggered by patch depolarization in rat heart cells. Circ Res 1998;82:424-429

35. Balke CW, Shorofsky SR. Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998;37:290-299

36. Shorofsky SR, Balke CW, Gwathmey JK. Calcium channels in cardiac hypertrophy and heart failure. Heart Failure Rev 1998;2:163-171

37. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR. Comparison of single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;31(6):1391-1394

38. Olsovsky MR, Pelini MA, Shorofsky SR, Gold MR. Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol 1998;9(3):240-244

39. Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Interventional Cardiac Electrophysiol 1998;2:367-370

40. Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. Effect of heart Rate on T wave alternans. J Cardiovasc Electrophysiol 1998;9(7):703-708

41. Weiss DN, Shorofsky SR, Peters RW, Gold MR. The effect of delivered energy on defibrillation shock impedance. J Interventional Cardiac Electrophysiol 1998;2:273-277.

42. Gold MR, Froman D, Kavesh NG, Peters RW, Foster AH, Shorofsky SR. A Comparison of pectoral and abdominal transvenous defibrillator implantation: Analysis of costs and outcomes. J Interventional Cardiac Electrophysiol 1998;2:345-349.

43. Olsovsky MR, Shorofsky SR, Gold MR. The effect of shock configuration and delivered energy on defibrillation impedance. Pacing Clin Electrophysiol. 1999;22:179-182.

44. Peters RW, Shorofsky SR, Pelini M, Olsovsky M, Gold MR. Overdrive atrial pacing for conversion of atrial flutter: Comparison of postoperative with nonpostoperative patients. Am Heart J 1999;137:100-103.

45. Shorofsky SR, Aggarwal R, Corretti M, Baffa JM, Strum JM, Kobayashi YM, Jones LR, Wier WG, Balke CW. Cellular mechanisms of altered contractility in the hypertrophied heart: big heart, big sparks. Circ Res 1999;84:424-434.

46. Balke CW, Goldman L, Aggarwal R, Shorofsky SR. Whether “slip-mode conductance” occurs. Science 1999; 284(5415):711.

47. Kavesh NG, Olsovsky MR, Freudenberger RS, Conte JV, Peters RW, Shorofsky SR, Gold MR. Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone. PACE 1999; 22(4):665-667.

48. Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. The effect of procainamide on T wave alternans. J Cardiovasc Electrophysiol. 1999; 10:649-654.

49. Gold MR, Hsu W, Marcovecchio AF, Olsovsky MR, Lang DJ, Shorofsky SR. A new defibrillator discrimination algorithm utilizing electrogram morphology analysis PACE 1999; 22:179-182.

50. Cooklin M, Tummala RV, Peters RW, Shorofsky SR, Gold MR. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J. 1999;138:133-136.

51. Cooklin M, Olsovsky MR, Brockman RG, Shorofsky SR, Gold MR. Atrial defibrillation with a transvenous lead. J Am Coll Cardiol 1999; 34(2):358-362.

52. Degeratu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiology; 2000; 11: 21-24.

53. Gold MR, Olsovsky MR, DeGroot PJ, Cuello C, Shorofsky SR. Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiology; 2000; 11: 25-29.

54. Pelini M, Peters RW, Khalighi K, Shorofsky SR, Gold MR. Short term escape rhythm characteristics after radiofrequency ablation of the atrioventricular function. J Interventional Cardiac Electrophysiol 2000; 4:301-305.

55. Gold MR, Brockman R, Peters RW, Olsovsky MR, Shorofsky SR. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;85:1106-1109.

56. Shorofsky SR, Gold MR. The Effect of Second Phase Duration on the Strength-Duration Relation for Human Transvenous Defibrillation Circ 2000; 102:2239-2242.

57. Shorofsky SR, Balke CW. Calcium currents and arrhythmias: insights from molecular biology. Am J Med 2001;110:127-140.

58. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk MM, Peters RW, Gold MR. Temporal decline in defibrillation thresholds with an active pectoral lead system. J Am Coll Cardiol 2001;38:1150-1155.

59. Chen-Izu Y, Shorofsky SR, Goldman L, Balke CWB. Ica(TTX) channels are distinct from those generating the classical cardiac Na+ current. Biophys J 2001; 81: 2647-2659.

60. Rashba EJ, Bouhouch R, Koshy S, MacMurdy K, Shorofsky SR, Peters RW, Gold MR. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight. Am J Cardiol 2001;88:1043-1045.

61. Kirk MM, Shorofsky SR, Gold MR. Comparison of the effects of active left and right pectoral pulse generators on defibrillation efficacy. Am J Cardiol. 2001;88:1308-1311.

62. Rashba EJ, Bouhouch R, MacMurdy KA, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J 2002;143:541-545.

63. Rashba EJ, Cooklin M, MacMurdy K, Kavesh N, Kirk M, Sarang S, Peters RW, Shorofsky SR, Gold MR. Effects of selective autonomic blockade on T-wave alternans in humans. Circ 2002;105:837-842.

64. Gilbert TB, Gold MR, Shorofsky SR, Hasnain JU, Ferguson MK, Foster AH. Cardiovascular responses to repetitive defibrillation during Implantable Cardioverter-defibrillator testing. J Cardiothoracic and Vasc Anesthesia 2002, 16:180-185.

65. Kirby SD, Gold MR, Rashba EJ, Shorofsky SR. Postentrainment activation sequence: diagnostic of the supraventricular tachycardia mechanism? J Cardovasc Electorphysiol 2002, 13:410-412.

66. Gold MR, Shorofsky SR, Bouhouch R, Joy RA, Kirby DS, Osman AF, Rashba EJ. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardovasc Electorphysiol 2002, 13:332-335.

67. Hodgson DM, Olsovsky MR, Shorofsky SR, Daly B, Gold MR. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator. PACE 2002, 25:408-413.

68. Shorofsky SR, Gold MR. T-wave alternans: Predictor of arrhythmic events? J. Cardiovasc Electrophysiol 2002, 13:513-514.

69. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 2002,13:770-775.

70. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002,13:845-850.

71. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for Implantable Cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002, 13:1092-1097.

72. Kirk M, Izu L, Chen-Izu Y, McCulle SL, Wier WG, Balke CWB, Shorofsky SR. Role of the transverse-axial tubule system in generating calcium sparks and calcium transients in rat atrial myocytes. J. Physiology 2003, 547:441-451.

73. Gold MR, Breiter D, Leman R, Rashba EJ, Shorofsky SR, Hahn SJ. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators PACE 2003;26:483-486.

74. Sha Q, Robinson SW, McCulle SL, Shorofsky SR, Welling PA, Goldman L, Balke CW. An antisense oligonucleotide against H1 inhibits the classical sodium current but not ICa(TTX) in rat ventricular cells. J Physiol 2003;547.2:435-440.

75. Shorofsky SR, Peters RW, Rashba EJ, Gold MR. Comparison of step-down and binary-search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol. 2004:27(2):218-220.

76. Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004:15:790-794.

77. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 2004; 15: 170-176.

78. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol 2004; 94(12):1572-4.

79. Rashba EJ, Shorofsky SR, Brown T, Peters RW, Gold MR. Clinical predictors of atrial defibrillation thresholds with a dual coil, active pectoral lead system. Heart Rhythm 2005, 2:49-54.

80. Olshansky B., Sami M, Rubin A, Kostis J, Shorofsky S, Slee A, Greene HL. Use of amiodarone for atrial fibrillation in patinents with preexisting pulmonary disease in the AFFIRM study. Am J Cardiol 2005, 495:404-405.

81. Voudouris AA, Khan EM, Hood RE, Shorofsky SR. Migration of an Accufix atrial lead retention wire to the anterior mediastinum. Heart Rhythm 2005, 2:215.

82. Shorofsky SR, Rashba E, Havel W, Belk P, Degroot P, Swerdlow C, Gold MR. Improved defibrillation efficacy with an ascending ramp waveform in humans. Heart Rhythm 2005, 2:388-394.

83. Khan EM, Voudouris AA, Hood RE, Shorofsky SR. Repositioning of a dislodged and fibrosed ventricular lead. J Interventional Card Electrophysiol 2005,13:1-3.

84. Hood RE, Shorofsky SR. Management of Arrhythmias in the Emergency Department. Card. Clinics 2006, 24:125-133.

85. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger Tm, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Gilkson M. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis. The detect supraventricular tachycardia study. Circulation 2006,113:2871-2879.

86. Rashba EJ, Shorofsky SR, Scheiner A, Peters RW, Ma C, Gold MR. Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 2006, 6:647-652.

87. Khan E, Voudouris A, Shorofsky SR, Peters RW. Inappropriate ICD discharges due to “triple counting” during normal rhythm. J Interv Card Electrophysiol 2006, 17:153-155.

88. Rao K, Fisher ML, Robinson S, Shorofsky S, Gottlieb SS. Effect of chronic changes in heart rate on congestive heart failure. J Card Fail. 2007, 13(4):269-74.

89. Armoundas AA, Rose J, Aggarwal R, Stuyvers BD, O'rourke B, Kass DA, Marban E, Shorofsky SR, Tomaselli GF, William Balke C. Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms.

Am J Physiol Heart Circ Physiol. 2007;292(3):H1607-18

90. Lieberman R, Havel W, Rashba E, DeGroot P, Stromberg K, Shorofsky S. Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients. Heart Rhythm 2008;5(1):28-33.

91. Dickfeld T, Lei P, Dilsizian V, Jeudy J, Dong J, Voudouris A, Peters R, Saba M, Shekhar R, Shorofsky S. Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. JACC Cardiovasc Imaging. 2008 Jan;1(1):73-82.

92. Vesely MR, Li S, Kop WJ, Reese A, Marshall J, Shorofsky SR, Gottlieb SS, Mehra MR, Gottdiener JS. Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol. 2008 101(5):645-50.

93. Tian J, Smith MF, Chinnadurai P, Dilsizian V, Turgeman A, Abbo A, Gajera K, Xu C, Plotnick D, Peters R, Saba M, Shorofsky S, Dickfeld T. Clinical Application of PET/CT Fusion Imaging for Three-Dimensional Myocardial Scar and Left Ventricular Anatomy during Ventricular Tachycardia Ablation. J Cardiovasc Electrophysiol. 2008 Dec 15.

94. Gammie JS, Didolkar P, Krowsoski LS, Santos MJ, Toran AJ, Young CA, Griffith BP, Shorofsky SR, Vander Salm TJ. Intermediate-term outcomes of surgical atrial fibrillation correction with the CryoMaze procedure. Ann Thorac Surg. 2009 May;87(5):1452-8.

95. Saba MM, Akella J, Gammie J, Poston R, Johnson A, Hood RE, Dickfeld TM, Shorofsky SR The influence of fat thickness on the human epicardial bipolar electrogram characteristics: measurements on patients undergoing open-heart surgery. Europace. 2009 Jul;11(7):949-53.

96. Shorofsky S. High-frequency vagal stimulation: pacing fast to slow down. Heart Rhythm. 2010 May;7(5):690-1.

97. Jiminez A, Saliaris A, Dickfeld T. Shorofsky SR Pacemaker/Implantable caridoverter-defibrillatior interaction. Heart Rhythm 2010 Aug;7(8):1157-60

98. Jimenez A, Shorofsky SR, Dickfeld TM, Ananad R, Saliaris AP, Saba M. Left-sided atrial flutter originating in the coronary sinus after radiofrequency ablation of atrial fibrillation. 2010 PACE: e1-e4.

99. Saba MM, Salim M, Hood RE, Dickfeld TM, Shorofsky SR. Idiopathic Ventricular Fibrillation in a 10-Year-Old Boy: Technical Aspects of Radiofrequency Ablation and Utility of Antiarrhythmic Therapy. Pacing Clin Electrophysiol. 2010 Jun 10.

100. Tian J, Jeudy J, Smith MF, Jimenez A, Yin X, Bruce PA, Lei P, Turgeman A, Abbo A, Shekhar R, Saba M, Shorofsky S, Dickfeld T. Three-dimensional contrast-enhanced multidetector CT for anatomic, dynamic, and perfusion characterization of abnormal myocardium to guide ventricular tachycardia ablations. Circ Arrhythm Electrophysiol. 2010 Oct 1;3(5):496-504.

101. Roberts BD, Hood RE, Saba MM, Dickfeld TM, Saliaris AP, Shorofsky SR Defibrillation threshold testing in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2010 Nov;33(11):1342-6.

102. Dickfeld T, Tian J, Ahmad G, Jimenez A, Turgeman A, Kuk R, Peters M, Saliaris A, Saba M, Shorofsky S, Jeudy J. MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium Enhanced 3D Scar in Patients with ICD. Circ Arrhythm Electrophysiol. 2011 Jan 26

103. Birgersdotter-Green U, Ruetz LL, Anand K, Monir G, Abeyratne AI, Bailey JR, Shorofsky SR, Hsia HH, Friedman PA. Automated vulnerability testing identifies patients with inadequate defibrillation safety margin. Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1073-80.

104. Shorofsky S. Defibrillation testing unplugged. Heart Rhythm. 2013 May;10(5):718-9

105. Ahmad G, Hussein AA, Mesubi O, Tian J, Ferieg H, Elmaaty MA, Hamdy A, Ego-Osuala K, Jimenez A, See V, Saliaris A, Shorofsky S, Dickfeld T. Impact of fluoroscopy unit on the accuracy of a magnet-based electroanatomic mapping and navigation system: an in vitro and in vivo validation study.. Pacing Clin Electrophysiol. 2014 Feb;37(2):157-63

106. Kuschyk J, Milasinovic G, Kühlkamp V, Roberts PR, Zabel M, Molin F, Shorofsky S, Stromberg KD, DeGroot PJ, Murgatroyd FD; Solo Study Investigators. A multicenter study of shock pathways for subcutaneous implantable defibrillators. J Cardiovasc Electrophysiol. 2014 Jan;25(1):29-35. doi: 10.1111/jce.12281

107. Hussein A, Jimenez A, Ahmad G, Mesubi O, Klein T, Gurm G, Beck H, Shams O, See V, Saliaris A, Shorofsky S, Dickfeld T. Assessment of Ventricular Tachycardia Scar Substrate by Intracardiac Echocardiography. Pacing Clin Electrophysiol. 2014 Apr:37(4):412-21.

108. Mohsen A, Jimenez A, Hood RE, Dickfeld T, Saliaris A, Shorofsky S, Saba Mbchb MM. Cardiac Sarcoidosis: Electrophysiological Outcomes on Long-Term Follow-Up and the Role of the Implantable Cardioverter-Defibrillator. J Cardiovasc Electrophysiol. 2013 Oct 8. doi: 10.1111/jce.12302

109. Watkins AC, Young CA, Ghoreishi M, Shorofsky SR, Gabre J, Dawood MY, Griffith BP, Gammie JS. Prospective Assessment of the CryoMaze Procedure With Continuous Outpatient Telemetry in 136 Patients. Ann Thorac Surg. 2014 Feb 25. pii: S0003-4975(13)02363-1.

110. Hussein A, Abutaleb A, Jeudy J, Phelan T, Patel R, Shkullaku M, Siddiqi F, See V, Saliaris A, Shorofsky SR, Dickfeld T. Safety of Computed Tomography Imaging in Patients with Cardiac Rhythm Management Devices: Assessment of the FDA Advisory in Real-world Practice. J Am Coll Cardiol. 2014 Feb 14. pii: S0735-1097(14)01097-3. 

111. Mesubi O, Ahmad G, Jeudy J, Jimenez A, Kuk R, Saliaris A, See V, Shorofsky S, Dickfeld T. Impact of ICD Artifact Burden on Late Gadolinium Enhancement Cardiac MR Imaging in Patients Undergoing Ventricular Tachycardia Ablation. Pacing Clin Electrophysiol. 2014 Apr 26. doi: 10.1111/pace.12405.

112. Abdulghani M, Duell J, Smith M, Chen W, Bentzen SM, Asoglu R, Klein T, Bob-Manuel T, Saliaris A, See V, Shorofsky S, Dilsizian V, Dickfeld T. Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123I-MIBG. J Nucl Med. 2015 Jun;56 Suppl 4:52S-58S.

113. Klein T, Abdulghani M, Smith M, Huang R, Asoglu R, Remo BF, Turgeman A, Mesubi O, Sidhu S, Synowski S, Saliaris A, See V, Shorofsky S, Chen W, Dilsizian V, Dickfeld T. Three-dimensional 123I-meta-iodobenzylguanidine cardiac innervation maps to assess substrate and successful ablation sites for ventricular tachycardia: feasibility study for a novel paradigm of innervation imaging. Circ Arrhythm Electrophysiol. 2015 Jun;8(3):583-91. 

114. Hussein A, Abutaleb A, Jeudy J, Phelan T, Patel R, Shkullaku M, Siddiqi F, See V, Saliaris A, Shorofsky SR, Dickfeld T. Reply: Effect of computed tomography imaging on rhythm devices in real-world practice. J Am Coll Cardiol. 2014 Dec 2;64(21):2302-3

Publications (Non-refereed)

1. Shorofsky SR, Balke CW. 2001. Calcium currents and arrhythmias: insights from molecular biology. Am J Med 110:127-140.

Book Chapters

1. Fozzard HA, Shorofsky SR. 1991. Excitable membranes. In: The Kidney: Physiology and pathophysiology (Eds: Seldin, D.W.; Giebisch, G.), Raven Press, New York

2. Brown JM, Gammie JS, Shorofsky S. 2004. Perioperative Arrhythmia. In: Surgical Decision Making, 5th edition. (Eds: McIntyreRC, Stiegmann GV, and Eiseman B.), Elsevier Saunders, Philadelphia, PA.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download